The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders

Autoimmunity Reviews

Volumn 7, Issue 8, 2008, Pages 621-625

  Ram, Maya ^a   Anaya, Juan Manuel ^b   Barzilai, Ori ^a   Izhaky, David ^a   Porat Katz, Bat sheva ^c   Blank, Miri ^a,d   Shoenfeld, Yehuda ^a,d  

^a SHEBA MEDICAL CENTER   (Israel)

^b Unidad de Biología Celular y Molecular   (Colombia)

^c KAPLAN MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoimmunity; Hepatitis B core antibody (HBcAb); Hepatitis B virus (HBV); Multiple sclerosis (MS); Rheumatoid arthritis (RA); Sjogren's syndrome (SS); Systemic lupus erythematosus (SLE); Type 1 diabetes (T1D)

Indexed keywords

HEPATITIS B CORE ANTIBODY; IMMUNOGLOBULIN G;

ANAMNESIS; ANTIBODY BLOOD LEVEL; AUTOIMMUNE DISEASE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; REVIEW; RHEUMATOID ARTHRITIS; SCREENING TEST; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOIMMUNE DISEASES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS; HUMANS;

EID: 50949126626     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2008.06.008     Document Type: Review

References (40)

1. Oertelt S., Invernizzi P., Podda M., and Gershwin M.E. What is an autoantibody. In: Shoenfeld Y., Gershwin M.E., and Meroni P.L. (Eds). Autoantibodies (2007), Elsevier, Amsterdam 3-6
2. Bogdanos D.P., Mieli-Vergani G., and Vergani D. Virus, liver and autoimmunity. Dig Liver Dis 32 5 (2000) 440-446
3. Hsu T.C., Tsay G.J., Chen T.Y., Liu Y.C., and Tzang B.S. Anti-PCNA autoantibodies preferentially recognize C-terminal of PCNA in patients with chronic hepatitis B virus infection. Clin Exp Immunol 144 1 (2006) 110-116
4. Huang C.F., Lin S.S., Ho Y.C., Chen F.L., and Yang C.C. The immune response induced by hepatitis B virus principal antigens. Cell Mol Immunol 3 2 (2006) 97-106
5. Bertoletti A., and Gehring A.J. The immune response during hepatitis B virus infection. J Gen Virol 87 Pt 6 (2006) 1439-1449
6. Ichiki Y., He X.S., Shimoda S., et al. T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity. Autoimmun Rev 4 2 (2005) 82-95
7. Lai K.N., Lai F.M., Chan K.W., Chow C.B., Tong K.L., and Vallance-Owen J. The clinico-pathologic features of hepatitis B virus-associated glomerulonephritis. Q J Med 63 240 (1987) 323-333
8. Chi Z.C., and Ma S.Z. Rheumatologic manifestations of hepatic diseases. Hepatobiliary Pancreat Dis Int 2 1 (2003) 32-37
9. Guillevin L., Lhote F., Cohen P., et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 74 5 (1995) 238-253
10. Trepo C., and Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun 16 3 (2001) 269-274
11. Tan E.M., Cohen A.S., Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 11 (1982) 1271-1277
12. Arnett F.C., Edworthy S.M., Bloch D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31 3 (1988) 315-324
13. Vitali C., Bombardieri S., Jonsson R., et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61 6 (2002) 554-558
14. McDonald W.I., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50 1 (2001) 121-127
15. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 7 (1997) 1183-1197
16. Anaya J.M., Uribe M., Perez A., et al. Clinical and immunological factors associated with lupus nephritis in patients from northwestern Colombia. Biomedica 23 3 (2003) 293-300
17. Gomez D., Correa P.A., Gomez L.M., Cadena J., Molina J.F., and Anaya J.M. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?. Semin Arthritis Rheum 33 6 (2004) 404-413
18. Cadena J., Vinaccia S., Perez A., Rico M.I., Hinojosa R., and Anaya J.M. The impact of disease activity on the quality of life, mental health status, and family dysfunction in Colombian patients with rheumatoid arthritis. J Clin Rheumatol 9 3 (2003) 142-150
19. Anaya J.M., Correa P.A., Mantilla R.D., and Arcos-Burgos M. Rheumatoid arthritis association in Colombian population is restricted to HLA-DRB1*04 QRRAA alleles. Genes Immun 3 1 (2002) 56-58
20. Anaya J.M., Mantilla R.D., and Correa P.A. Immunogenetics of primary Sjogren's syndrome in Colombians. Semin Arthritis Rheum 34 5 (2005) 735-743
21. Sanchez J.L., Palacio L.G., Uribe C.S., et al. Clinical features of multiple sclerosis in a genetically homogeneous tropical population. Mult Scler 7 4 (2001) 227-229
22. Tobon G.J., Arango A., Abad V., et al. Clinical and immunological characteristics of type 1 diabetes mellitus in a northwestern Colombian population. Diabetes Res Clin Pract 72 2 (2006) 170-175
23. In: Shoenfeld Y., and Rose N.R. (Eds). Infection and Autoimmunity (2004), Elsevier, Amsterdam, 1-747 Netherlands
24. Echevarria J.M., and Leon P. Epidemiology of viruses causing chronic hepatitis among populations from the Amazon Basin and related ecosystems. Cad Saude Publica 19 6 (2003) 1583-1591
25. Barzilai O., Sherer Y., Ram M., Izhaky D., Anaya J., and Shoenfeld Y. Epstein-Barr virus and cytomegalovirus in autoimmune diseases. Are they truly notorious?. A Preliminary Report. Ann NY Acad Sci 1108 (2007) 567-577
26. Elkayam O., Paran D., Caspi D., et al. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Infect Dis 34 2 (2002) 147-153
27. Mercado U., Acosta H., and Avendano L. Influenza vaccination of patients with systemic lupus erythematosus. Rev Invest Clin 56 1 (2004) 16-20
28. Geier D.A., and Geier M.R. A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 38 4 (2005) 295-301
29. Ziegenfuss J., Bergquist E., and Burka E. Australia antigen in systemic lupus erythematosus. N Engl J Med 286 15 (1972) 842-843
30. Looi L.M., and Prathap K. Hepatitis B virus surface antigen in glomerular immune complex deposits of patients with systemic lupus erythematosus. Histopathology 6 2 (1982) 141-147
31. Girard M. Autoimmune hazards of hepatitis B vaccine. Autoimmun Rev 4 2 (2005) 96-100
32. Piaggio E., Ben Younes A., Desbois S., et al. Hepatitis B vaccination and central nervous system demyelination: an immunological approach. J Autoimmun 24 1 (2005) 33-37
33. Berkun Y., Mimouni D., and Shoenfeld Y. Pemphigus following hepatitis B vaccination-coincidence or causality?. Autoimmunity 38 2 (2005) 117-119
34. Bach J.F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347 12 (2002) 911-920
35. Bach J.F. Protective role of infections and vaccinations on autoimmune diseases. J Autoimmun 16 3 (2001) 347-353
36. Bach J.F. Six questions about the hygiene hypothesis. Cell Immunol 233 2 (2005) 158-161
37. Bogdanos D.P., Smith H., Ma Y., Baum H., Mieli-Vergani G., and Vergani D. A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics. Clin Dev Immunol 12 3 (2005) 217-224
38. Bach J.F. Infections and autoimmune diseases. J Autoimmun 25 (2005) 74-80 Suppl
39. Selmi C., Lleo A., Zuin M., Podda M., Rossaro L., and Gershwin M.E. Interferon alpha and its contribution to autoimmunity. Curr Opin Investig Drugs 7 5 (2006) 451-456
40. Osborn M.K., and Lok A.S. Antiviral options for the treatment of chronic hepatitis B. J Antimicrob Chemother 57 6 (2006) 1030-1034